PMID: 42020366

Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia.

Yuan Lunzhi, Xiao Haiqing, Liu Xuan, Zhou Ming, Zhang Chang, Wu Kun, Ye Jianghui, Zhang Longmei, Li Xinglin, Ma Jian

Signal transduction and targeted therapy · 2026

Vol. 11, Issue 1

This entry links to third-party literature. For research use only.

AnimalsMaleFemaleDrug RepositioningTestosteroneCOVID-19SARS-CoV-2COVID-19 Drug TreatmentFinasterideSex Characteristics

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.